Active Stocks
Tue Mar 05 2024 15:01:29
  1. ICICI Bank share price
  2. 1,090.05 -0.16%
  1. Tata Motors share price
  2. 1,023.80 3.71%
  1. Tata Steel share price
  2. 152.05 -0.69%
  1. NTPC share price
  2. 358.05 1.20%
  1. Titan Company share price
  2. 3,751.95 0.54%
Business News/ Industry / Manufacturing/  Mylan-Biocon seek USFDA nod for biosimilar version of cancer drug
BackBack

Mylan-Biocon seek USFDA nod for biosimilar version of cancer drug

The proposed biosimilar version of trastuzumab is indicated for treatment of certain breast and gastric cancers

Mylan and Biocon said that their application has the potential to be the first submission of a proposed biosimilar trastuzumab in the US. Photo: MintPremium
Mylan and Biocon said that their application has the potential to be the first submission of a proposed biosimilar trastuzumab in the US. Photo: Mint

Hyderabad: Drug makers Mylan NV and Biocon Ltd on Tuesday said they had submitted their first biologics licence application (BLA) to the US Food and Drug Administration (USFDA) seeking approval for a biosimilar version of cancer drug trastuzumab in the US.

The proposed biosimilar version of trastuzumab is indicated for treatment of certain breast and gastric cancers.

Mylan and Biocon said in a statement they believed that their application has the potential to be the first submission of a proposed biosimilar trastuzumab in the US

Also Read: European regulator EMA to review Biocon-Mylan’s version of insulin glargine

A biosimilar is a complex biological product that follows a different approval pathway compared to chemical drugs.

Biosimilars involve clinically testing the drug on animals and humans to demonstrate that the drug is highly similar to the innovator biological product (known as a reference product) and has no clinically meaningful differences in terms of safety and effectiveness from it.

Unlock a world of Benefits! From insightful newsletters to real-time stock tracking, breaking news and a personalized newsfeed – it's all here, just a click away! Login Now!

Catch all the Industry News, Banking News and Updates on Live Mint. Check all the latest action on Budget 2024 here. Download The Mint News App to get Daily Market Updates.
More Less
Published: 08 Nov 2016, 11:10 PM IST
Next Story footLogo
Recommended For You
Manufacturing Stocks
₹525.1-0.57%
ITC
₹409.1-0.56%
₹3,011.6-0.14%
₹153.1-0.72%
Switch to the Mint app for fast and personalized news - Get App